Monthly Archives: June 2018

Northwell Health, Feinstein Institute executives chosen to advise Sanguistat

Posted

MANHASSET, NY – The Feinstein Institute for Medical Research President and CEO Kevin J. Tracey, MD, along with Northwell Health Senior Vice President, Clinical Strategy and Development, and Associate Chief Medical Officer Martin Doerfler, MD, will each play key roles in the emerging Connecticut-based biotech company Sanguistat, Inc. Announced at Sanguistat’s first board meeting this month, both… read more

posted in: Press Releases

Leading mitochondrial DNA researcher discusses causes of common complex diseases at Feinstein Institute Marsh Lecture

Posted

MANHASSET, NY – The Feinstein Institute for Medical Research hosted a Marsh Lecture this week by Douglas C. Wallace, PhD, a renowned leader in mitochondrial DNA research and director of the Center for Mitochondrial and Epigenomic Medicine at Children’s Hospital of Philadelphia. Dr. Wallace discussed his research to determine the mitochondrial causes of common “complex” diseases. Dr…. read more

posted in: Press Releases

Elmezzi Scholar wins pediatric surgery research award

Posted

MANHASSET, NY – The Feinstein Institute for Medical Research’s Caroline Maloney, MD, received The American Pediatric Surgical Association’s (APSA) M. Judah Folkman Memorial Award for her research in identifying a drug’s potential to prevent bone tumors from spreading, a process called metastasis. Surgery is often the primary course of action to stop a cancer from growing, but… read more

posted in: Press Releases

Feinstein Institute scientist recognized for anticoagulation management practices

Posted

MANHASSET, NY – Feinstein Institute for Medical Research Professor Alex C. Spyropoulos, MD, earned the 2018 IPRO Quality Award for championing, developing and educating health care professionals in anticoagulation management best practices. The award was presented during a ceremony at the annual meeting of the quality improvement organization IPRO. “I am honored to be recognized for my… read more

posted in: Press Releases

Latest bioelectronic medicine discoveries focus of Feinstein Institute-hosted symposium

Posted

STOCKHOLM – Leading researchers from neuroscience, molecular biology and bioengineering, discussed discoveries that drive the field of bioelectronic medicine forward at a recent three-day symposium. The Feinstein Institute for Medical Research, the Karolinska Institutet and its journal, the Journal of Internal Medicine, hosted “Bioelectronic Medicine: Technology Targeting Molecular Mechanisms,” which took place June 12-14 in Stockholm Sweden. “With discoveries announced, the pace of bioelectronic medicine is accelerating,” said Kevin J. Tracey, MD, president and CEO of the… read more

posted in: Press Releases

Elmezzi Scholar named public policy fellow of the American Association of Immunologists

Posted

MANHASSET, NY – Feinstein Institute for Medical Research Elmezzi Graduate School of Molecular Medicine Scholar Gavin H. Imperato, MD, has been named a Public Policy Fellow of the American Association of Immunologists (AAI) for 2018-2019. Dr. Imperato is a PhD candidate at the Elmezzi Graduate School where he studies the neuroscience of immunity. He works with researchers… read more

posted in: Press Releases

Chad Bouton discusses the future of Bioelectronic Medicine at the 2018 BIO International Convention

Posted

Professor Chad Bouton joins leaders in bioelectronic medicine to discuss how nerve and brain implants can revolutionize treatment of disease and debilitating injury during a panel discussion at the 2018 BIO International Convention. Click here to view event details.

posted in: Press Releases

Blood markers identify lupus risk, Feinstein Institute researchers find

Posted

MANHASSET, NY – Feinstein Institute for Medical Research Professor Betty Diamond, MD, and colleagues discovered what they believe can identify a person’s risk for lupus by looking at the presence and amount of antibodies and a protein complex in blood. Health care professionals could now feasibly use these markers to anticipate which lupus patients might benefit from… read more

posted in: Press Releases